Market Overview:
The global spasticity treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of spasticity, rising awareness about available treatments, and growing demand for better and more effective therapies. The global spasticity treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is divided into physical treatment and medicine treatment. Physical treatment dominates the global spasticity treatment market owing to its high efficacy in treating various types of spasticity disorders.
Product Definition:
Spasticity Treatment is a medical term used to describe the various treatments available for reducing muscle spasms and stiffness caused by Spasticity. Importance of Spasticity Treatment: -Muscle spasms and stiffness can cause pain, interfere with movement, and make it difficult to perform everyday activities. -Treatment can help reduce muscle spasms and improve movement and function.
Physical Treatment:
Physical treatments are non-invasive and painless. They include active release, trigger point therapy, muscle energy technique, myofascial release and soft tissue massage. Physical treatments can be used for the treatment of spasticity due to multiple sclerosis or cerebral palsy as well as other conditions like orthopedic disorders & stroke.
Medicine Treatment:
Spasticity is a common condition associated with multiple sclerosis. It is most commonly observed in the lower extremities of patients and may occur as a primary symptom or as a result of secondary symptoms such as bladder control problems, walking problems, or pain. Spasticity can affect any part of the body but mainly involves muscles that use more than 25% of your muscle mass (such as legs, arms and trunk).
Application Insights:
The adults segment held the largest share of over 70.0% in 2017. The treatment is most effective when it targets the core symptoms of spasticity such as stiffness, pain and cramping in muscles. These symptoms are usually present in spastic muscles and lead to reduced mobility and quality of life for patients suffering from cerebral palsy or spinal cord injuries.
Physical therapy is one of the most common forms used for treating spasticity due to CP or SCI but there are other treatments such as botulinum toxin injections that have shown positive results too, therefore offering alternative options for treating this condition without having to undergo physical therapy sessions every day.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of patients suffering from spasticity, increasing awareness about available treatment options, and availability of highly advanced healthcare infrastructure. Moreover, rising incidence of neurodegenerative conditions such as Parkinson’s disease (PD) and multiple sclerosis (MS), which are known to cause muscle stiffness and spasms, is expected to drive regional growth over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to improving healthcare facilities in developing countries such as India and China. In addition, growing medical tourism industry due to availability of effective treatments at low cost will also boost demand for Botox injections in these regions thereby driving regional revenue share over the next eight years. For instance; according Spastics International Research Center Inc.
Growth Factors:
- Increasing incidence of spasticity due to rising prevalence of neurological disorders such as cerebral palsy, multiple sclerosis, and stroke.
- Growing demand for minimally invasive procedures for the treatment of spasticity.
- Rising awareness about available treatment options for spasticity among patients and healthcare professionals.
- Technological advancements in the field of spasticity treatment that offer improved patient outcomes and reduced side effects.
Scope Of The Report
Report Attributes
Report Details
Report Title
Spasticity Treatment Market Research Report
By Type
Physical Treatment, Medicine Treatment
By Application
Children, Adults
By Companies
Codman & Shurtleff, Medtronic, Sanofi, InMed Pharmaceuticals, Ipsen, Orient Pharma, Taj Pharmaceuticals, MediciNova, Genentech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
142
Number of Tables & Figures
100
Customization Available
Yes, the report can be customized as per your need.
Global Spasticity Treatment Market Report Segments:
The global Spasticity Treatment market is segmented on the basis of:
Types
Physical Treatment, Medicine Treatment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Children, Adults
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Codman & Shurtleff
- Medtronic
- Sanofi
- InMed Pharmaceuticals
- Ipsen
- Orient Pharma
- Taj Pharmaceuticals
- MediciNova
- Genentech
Highlights of The Spasticity Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Physical Treatment
- Medicine Treatment
- By Application:
- Children
- Adults
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Spasticity Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Spasticity treatment is a type of medical treatment that helps to reduce spasticity, or stiffness, in the muscles. This can help to improve mobility and function.
Some of the major players in the spasticity treatment market are Codman & Shurtleff, Medtronic, Sanofi, InMed Pharmaceuticals, Ipsen, Orient Pharma, Taj Pharmaceuticals, MediciNova, Genentech.
The spasticity treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Spasticity Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Spasticity Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Spasticity Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Spasticity Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Spasticity Treatment Market Size & Forecast, 2018-2028
4.5.1 Spasticity Treatment Market Size and Y-o-Y Growth
4.5.2 Spasticity Treatment Market Absolute $ Opportunity
Chapter 5 Global Spasticity Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Spasticity Treatment Market Size Forecast by Type
5.2.1 Physical Treatment
5.2.2 Medicine Treatment
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Spasticity Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Spasticity Treatment Market Size Forecast by Applications
6.2.1 Children
6.2.2 Adults
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Spasticity Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Spasticity Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Spasticity Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Spasticity Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Spasticity Treatment Market Size Forecast by Type
9.6.1 Physical Treatment
9.6.2 Medicine Treatment
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Spasticity Treatment Market Size Forecast by Applications
9.10.1 Children
9.10.2 Adults
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Spasticity Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Spasticity Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Spasticity Treatment Market Size Forecast by Type
10.6.1 Physical Treatment
10.6.2 Medicine Treatment
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Spasticity Treatment Market Size Forecast by Applications
10.10.1 Children
10.10.2 Adults
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Spasticity Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Spasticity Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Spasticity Treatment Market Size Forecast by Type
11.6.1 Physical Treatment
11.6.2 Medicine Treatment
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Spasticity Treatment Market Size Forecast by Applications
11.10.1 Children
11.10.2 Adults
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Spasticity Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Spasticity Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Spasticity Treatment Market Size Forecast by Type
12.6.1 Physical Treatment
12.6.2 Medicine Treatment
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Spasticity Treatment Market Size Forecast by Applications
12.10.1 Children
12.10.2 Adults
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Spasticity Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Spasticity Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Spasticity Treatment Market Size Forecast by Type
13.6.1 Physical Treatment
13.6.2 Medicine Treatment
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Spasticity Treatment Market Size Forecast by Applications
13.10.1 Children
13.10.2 Adults
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Spasticity Treatment Market: Competitive Dashboard
14.2 Global Spasticity Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Codman & Shurtleff
14.3.2 Medtronic
14.3.3 Sanofi
14.3.4 InMed Pharmaceuticals
14.3.5 Ipsen
14.3.6 Orient Pharma
14.3.7 Taj Pharmaceuticals
14.3.8 MediciNova
14.3.9 Genentech
